Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Unknown 1Recruiting 1

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Gynecologic 2

Conditions

Uterine Cervical Neoplasms 5Endometrial Neoplasms 4Ovarian Neoplasms 2Locally Advanced Cervical Carcinoma 2Turcot syndrome 1Stomach Neoplasms 1Recurrent/ Advanced Stage Endometrial Cancer Patients 1Recurrence 1Esophageal Neoplasms 1Colorectal Neoplasms 1Carcinoma, Endometrioid 1Advanced Cervical Cancer 1

Interventions

Cisplatin 4sintilimab 2Radiation Dose Hypofractionation 1Radiation 1Platinum 1Irinotecan 1Immunotherapy 1Brachytherapy 1Albumin-Bound Paclitaxel 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Locally Advanced Cervical Carcinoma × sintilimab × Gynecologic × Clear all
NCT06391190 2024-04-30

Concurrent Chemoradiotherapy Followed by PD-1 Inhibitor in Advanced Cervical Cancer

RenJi Hospital

Phase 1/2 Recruiting
20 enrolled
Gynecologic

Locally Advanced Cervical Carcinoma

NCT06378840 2024-04-23

the Predictive Value of Immune Cell in Locally Advanced Cervical Cancer

RenJi Hospital

Unknown
20 enrolled
Gynecologic

Locally Advanced Cervical Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡